Qianjin Pharmaceutical

Zhuzhou Qianjin Pharmaceutical Co., Ltd. ("Qianjin Pharmaceutical") is a listed pharmaceutical enterprise controlled by the Zhuzhou municipal government. It was founded in 1966 as a traditional Chinese medicine processing plant, underwent shareholding reform in 1993, and was listed on the Shanghai Stock Exchange in 2004. The group's business covers pharmaceutical manufacturing, pharmaceutical trading, hygiene products and women's health, with five industrial enterprises and four commercial enterprises. Its main products include the gynecological medicines Qianjin tablets/capsules and Buxue Yimu pills/granules, as well as chemical drugs such as lamivudine tablets and valsartan capsules. In 2024 the group released a 2024-2031 strategic plan aiming to become one of China's top 100 pharmaceutical industrial enterprises and a benchmark enterprise for women's health nationwide. The supplied seed text identifies Qianjin Pharmaceutical as a traditional Chinese medicine brand. The evidence does not establish its product range, founding, ownership, headquarters, markets, or corporate history. The supplied website returned a 404 Not Found response, so it does not provide usable official information for this dossier.

The predecessor of Zhuzhou Qianjin Pharmaceutical Co., Ltd. was founded in 1966 as the Zhuzhou Municipal Traditional Chinese Medicine Processing Plant (also known as the Zhuzhou Municipal Pharmaceutical Company Xinghuo Traditional Chinese Medicine Processing Plant), located in Xujiaqiao, Lusong District, Zhuzhou. In 1968 it was renamed Zhuzhou 626 Pharmaceutical Factory; in 1975 it was renamed Zhuzhou Traditional Chinese Medicine Pharmaceutical Factory; in 1979 the "Peony" trademark was registered and Qianjin tablets obtained production approval for trial production; in 1987 it was renamed Zhuzhou Traditional Chinese Medicine Factory. In 1993 the company completed shareholding reform and was renamed Zhuzhou Qianjin Pharmaceutical Co., Ltd. In 1995 the "Qianjin" trademark obtained a registered trademark certificate from the State Administration for Industry and Commerce. In 1998 it established the Longxi Medicinal Materials Branch, Xiangjiang Pharmaceutical Co., Ltd. (in which Qianjin Pharmaceutical invested 8.16 million yuan for 51% of shares), and Zhuzhou Qianjin Pharmaceutical Trading Co., Ltd. In 2004 it was listed on the Shanghai Stock Exchange. In 2024 the group released the "Three New Navigations, Entering the Top 100" 2024-2031 strategic plan. Qianjin Pharmaceutical (千金药业) is a Chinese brand associated with traditional Chinese medicine (TCM) and 中成药 (Chinese patent medicines). The available evidence identifies it as a TCM brand within the broader category of 中药品牌 (Chinese medicine brands), a sector that also includes related traditions such as Kampo in Japan. The brand's official website domain is qianjin.com, although the homepage currently returns a 404 error. No further verifiable details about the company's founding, ownership, or corporate history are present in the supplied evidence.

Aiming to become one of China's top 100 pharmaceutical industrial enterprises and a benchmark enterprise for women's health nationwide. Identified by the supplied seed text as a traditional Chinese medicine brand; further positioning is unverified.

• 妇科千金片

  Indications: clears heat and removes dampness, replenishes qi and resolves stasis. Used for leukorrhea and abdominal pain caused by damp-heat stasis, and for chronic pelvic inflammatory disease with the above symptoms.

• 妇科千金胶囊

  Indications: clears heat and removes dampness, replenishes qi and resolves stasis. Used for leukorrhea and abdominal pain caused by damp-heat stasis, and for chronic pelvic inflammatory disease with the above symptoms.

• 千金止带丸（水丸）

  Indications: strengthens the spleen and tonifies the kidney, regulates menstruation and stops leukorrhea. Used for irregular menstruation and leukorrhea due to spleen-kidney deficiency.

• 妇科调经片

  Indications: nourishes blood and softens the liver, regulates qi and menstruation. Used for irregular menstruation and menstrual abdominal pain due to liver depression and blood deficiency.

• 加味逍遥丸

  Indications: soothes the liver and clears heat, strengthens the spleen and nourishes blood. Used for liver depression and blood deficiency, disharmony of liver and spleen, hypochondriac distension and pain, dizziness, fatigue and poor appetite, irregular menstruation, and abdominal distension and pain.

• 八珍益母片

  Indications: tonifies qi and blood, regulates menstruation. Used for dizziness and palpitations, fatigue and weakness, scanty and pale menstruation, and delayed menstruation.

• Chinese patent medicines (中成药)

  The brand operates in the traditional Chinese medicine sector, which includes Chinese patent medicines (中成药).

• 2017

  Qianjin Pharmaceutical subsidiary fined over dyed safflower decoction pieces; earlier Fuke Qianjin Tablets failed sampling

  In January 2017, safflower decoction pieces from Qianjin Pharmaceutical subsidiary Zhuzhou Qianjin Medicinal Materials tested positive for dyes including tartrazine and carmine; illegal gains of RMB 28,630 were confiscated and a fine of RMB 57,384 was imposed. The company said the procurement source had already been dyed and that it did not itself test for dyes. In October 2013, its flagship product Fuke Qianjin Tablets was notified in drug sampling for failing due to characteristics (discoloration from moisture absorption); the company said this was caused by damaged aluminum foil packaging and storage/transport factors. Status: administrative penalty. Entity involved: Zhuzhou Qianjin Pharmaceutical Co., Ltd. Scope: Qianjin Pharmaceutical's traditional Chinese medicine decoction pieces and Fuke Qianjin Tablets.

  Source

Read more

1. 1首页 - 株洲千金药业股份有限公司官网qjyy.com
2. 2中药 - 株洲千金药业股份有限公司官网qjyy.com
3. 3公司介绍 - 株洲千金药业股份有限公司官网qjyy.com
4. 4千金品牌连续14年荣膺“健康中国品牌榜”妇科用药西普金奖 - 株洲千金药业股份有限公司官网qjyy.com
5. 5Qianjin Pharmaceuticalwikidata.org
6. 6千金药业zh.wikipedia.org
7. 7404 Not Foundqianjin.com
8. 8Qianjin Pharmaceutical subsidiary fined over dyed safflower decoction pieces; earlier Fuke Qianjin Tablets failed samplingstock.gucheng.com
9. 9Qianjin Pharmaceutical subsidiary fined over dyed safflower decoction pieces; earlier Fuke Qianjin Tablets failed samplingecon.taiwan.cn
10. 10Qianjin Pharmaceutical subsidiary fined over dyed safflower decoction pieces; earlier Fuke Qianjin Tablets failed samplingcs.com.cn